Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study.
Yıldırım HÇ, Mutlu E, Chalabiyev E, Özen M, Keskinkılıç M, Ön S, Çelebi A, Dursun B, Acar Ö, Kahraman S, Aykan MB, Kaman Ö, Doğan A, Erdoğan AP, Melisa Celayir Ö, Günenç D, Güven DC, Vedat Bayoğlu İ, Yavuzşen T, Hacıbekiroğlu İ, İnanç M, Kılıçkap S, Yalçın Ş, Aksoy S. Yıldırım HÇ, et al. Among authors: inanc m. Breast. 2022 Dec;66:85-88. doi: 10.1016/j.breast.2022.09.009. Epub 2022 Sep 30. Breast. 2022. PMID: 36208540 Free PMC article.
Clinicopathological characteristics and prognosis of patients according to recurrence time after radical nephrectomy for localized renal cell carcinoma: a multicenter study of Anatolian Society of Medical Oncology (ASMO).
Bozkurt O, Inanc M, Hacibekıroglu I, Esbah O, Seker M, Ulas A, Aydin K, Uysal M, Kücüköner M, Uncu D, Cıltas A, Unal OÜ, Durnali A, Demırcı U, Berk V, Tonyali O, Oksüzoglu B, Karaca H, Ozkan M. Bozkurt O, et al. Among authors: inanc m. Anticancer Res. 2014 Aug;34(8):4463-70. Anticancer Res. 2014. PMID: 25075086
XELOX plus bevacizumab vs. FOLFIRI plus bevacizumab treatment for first-line chemotherapy in metastatic colon cancer: a retrospective study of the Anatolian Society of Medical Oncology.
Duran AO, Karaca H, Besiroglu M, Bayoglu IV, Menekse S, Yapici HS, Yazilitas D, Bahceci A, Uysal M, Sevinc A, Hacibekiroglu I, Aksoy A, Tanriverdi O, Arpaci E, Inanc M, Dane F, Ozkan M. Duran AO, et al. Among authors: inanc m. Asian Pac J Cancer Prev. 2014;15(23):10375-9. doi: 10.7314/apjcp.2014.15.23.10375. Asian Pac J Cancer Prev. 2014. PMID: 25556478 Free article.
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab.
Tonyali O, Coskun U, Yuksel S, Inanc M, Bal O, Akman T, Yazilitas D, Ulas A, Kucukoner M, Aksoy A, Demirci U, Uysal M, Tanriverdi O, Gunaydin Y, Sumbul AT, Yildiz R, Karaca H, Oksuzoglu B, Ciltas A, Buyukberber S, Benekli M; Anatolian Society of Medical Oncology (ASMO). Tonyali O, et al. Among authors: inanc m. Breast. 2016 Feb;25:22-6. doi: 10.1016/j.breast.2015.11.006. Epub 2015 Dec 20. Breast. 2016. PMID: 26801412
The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients: A Multicenter Real-Life Study.
Akdeniz N, Kaplan MA, İnanç M, Uncu D, Ergün Y, Küçüköner M, Demirci A, Şendur MAN, Beşiroğlu M, Topçu A, Yerlikaya H, Urakçi Z, Kiliçkap S, Işikdoğan A. Akdeniz N, et al. Among authors: inanc m. Pancreas. 2022 Oct 1;51(9):1153-1159. doi: 10.1097/MPA.0000000000002167. Pancreas. 2022. PMID: 37078939
Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.
Elkiran ET, Kaplan MA, Sevinc A, Aksoy S, Demirci U, Seker M, Harputluoglu H, Ozdemir NY, Isik F, Ulas A, Inanc M, Arslan UY, Dogu GG, Isikdogan A, Buyukberber S; Anatolian Society of Medical Oncology Group. Elkiran ET, et al. Among authors: inanc m. Med Oncol. 2012 Dec;29(5):3147-54. doi: 10.1007/s12032-012-0276-y. Epub 2012 Jun 22. Med Oncol. 2012. PMID: 22722923
412 results